AKT1 and non-small cell lung carcinoma: KEGG enrichment analysis indicated that luteolin against NSCLC via the PI3K-Akt signaling pathway, proteoglycans in cancer, NF-kappa B signaling pathway, and transcriptional misregulation in cancer.